Log in Free sign up

Biondvax Pharmaceuticals (BVXV) News and press releases

News

From Benzinga Pro

12 Health Care Stocks Moving In Friday's After-Market Session

Gainers Trevena (NASDAQ:TRVN) shares moved upwards by 13.3% to $0.23 during Friday's after-market session. The market value of their outstanding shares is at $38.0 million. As per the news, the Q1 earnings report came out 2 days ago.

BVXV: Definitive Collaboration Agreement Signed to Develop Pipeline of NanoAb Therapies…

By David Bautz, PhD NASDAQ:BVXV READ THE FULL BVXV RESEARCH REPORT

80 Biggest Movers From Yesterday

News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas

Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 93.1% to close at $6.45 on Tuesday on above-average volume.

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Pre-Market Outlook, Markets, Movers

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Pre-Market Outlook, Markets, Movers

12 Health Care Stocks Moving In Friday's Pre-Market Session

Pre-Market Outlook, Markets, Movers

34 Stocks Moving in Friday's Pre-Market Session

News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas

Gainers Clever Leaves Holdings Inc. (NASDAQ: CLVR) rose 40.5% to $2.22 in pre-market trading after the company reported better-than-expected Q4 sales results and reaffirmed FY22 guidance.

63 Biggest Movers From Yesterday

News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas

Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares gained 39.1% to close at $1.05 on Thursday. The company recently said its CFO Bruce Colwill will retire.

12 Health Care Stocks Moving In Thursday's Intraday Session

Intraday Update, Markets, Movers

Here's Why Biondvax Pharmaceuticals Shares Are Rising

Penny Stocks, Movers, Trading Ideas

Biondvax Pharmaceuticals Ltd - ADR (NASDAQ: BVXV) shares are trading higher by 32.1% at $1.81 after the company announced it signed a definitive collaboration agreement for the development of a pipeline of innovative nanosized antibody therapies.

Why Are BiondVax Pharma Shares Gaining Today?

Biotech, News, Penny Stocks, Health Care, Contracts, Movers, Trading Ideas, General

BiondVax Pharmaceuticals Ltd (NASDAQ: BVXV) has

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Pre-Market Outlook, Markets, Movers

The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL

Biotech, News, Penny Stocks, Offerings, Small Cap, FDA, General

Here's a roundup of top developments in the biotech space over the last 24 hours:

Biondvax Signed Definitive Collaboration Agreement for the Development of a Pipeline of Innovative Nanosized Antibody (Nanoab) Therapies

News, Penny Stocks

BiondVax Pharmaceuticals Ltd.

Stocks That Hit 52-Week Lows On Tuesday

News, Options, Intraday Update, Markets, Movers, Trading Ideas

During Tuesday's trading, 505 companies set new 52-week lows.

Press releases

From Benzinga Pro

BiondVax to Present at H.C. Wainwright Global Investment Conference

JERUSALEM, May 19, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and

BiondVax Provides Update at Biomed Israel Conference and Announces Significant Progress in its Nanosized Antibodies Program

JERUSALEM, May 12, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and

BiondVax to Present at this week's Biomed Israel Conference

JERUSALEM , May 9, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and

BiondVax to host a Hebrew-language analyst and investor webinar on April 6th

Small Cap, Press Releases

JERUSALEM, April 5, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and

BiondVax to host analyst and investor webinar on April 4th

Small Cap, Press Releases

JERUSALEM, March 31, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and

BiondVax Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

Earnings, Press Releases

JERUSALEM, March 28, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and

Thinking about buying stock in Nikola Corp, D-Market Electronic Services, Biondvax Pharmaceuticals, Trip.com, or Spectrum Pharmaceuticals?

Small Cap, Opinion, Press Releases

NEW YORK, March 24, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NKLA, HEPS, BVXV, TCOM, and SPPI.

BiondVax signs definitive collaboration agreement for the development of a pipeline of innovative nanosized antibody (NanoAb) therapies

News, Contracts, Small Cap, Press Releases

JERUSALEM, March 24, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and

European Investment Bank Agrees in Principle to Extend the Maturity of its Loan until December 2027 with Additional Terms that Provide Continued Long-Term Support for BiondVax's New Strategy

News, Contracts, Press Releases

JERUSALEM, March 14, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) announced today that it had been negotiating with the European Investment Bank (the "EIB") terms of restructuring of its

BiondVax to Present at Aegis Virtual Conference

JERUSALEM, Feb. 22, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and